Financials
- Market Capitalization 2.48 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
13.24
ratio cours/chiffre d'affaires
2.13
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1622 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 6.89 USD | +6.33% | +25.73% | +15.60% | -47.72% | 3.41 B USD | ||
| 1848 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.53 USD | -1.00% | -0.02% | -7.46% | -19.39% | 2.53 B USD | ||
| 1867 | HCM HUTCHMED (China) Limited - American Depositary Shares | 14.09 USD | -0.14% | +13.26% | +22.10% | -13.45% | 2.46 B USD | ||
| 1869 | BHC Bausch Health Companies Inc. Common Stock | 6.56 USD | -2.96% | +3.14% | +3.31% | -10.38% | 2.45 B USD |